Over the Counter Drugs Market By Product Type (Analgesics, Cold & Cough Remedies, Digestive & Intestinal Remedies, Weight Loss Products, Gastrointestinal Products Skin Treatment, Vitamins & Minerals Supplements, Sleeping Aids, Ophthalmic Products, Others), By Dosage Type (Tablets, Liquids, Ointments, Hard Capsules, Powders, Soft Capsules, Sprays), By Distribution Channel (Drug Store & Retail Pharmacies, Hospital Pharmacies, Online Pharmacies), and By Region - Trends, Analysis and Forecast till 2034

Report Code: PMI505723 | Publish Date: March 2024 | No. of Pages: 175

Over The Counter Drugs Market Companies

  • Pfizer
  • Bayer AG
  • Sanofi S.A.
  • Novartis AG
  • Boehringer Ingelheim International GmbH
  • AstraZeneca
  • Bristol Myers Squibb
  • Reckitt Benckiser Group PLC
  • Takeda Pharmaceutical Company Ltd.

Recent News:

  • In April 2024, Amneal Pharmaceuticals Inc. received U.S. Food and Drug Administration approval for the over-the-counter naloxone hydrochloride nasal spray, which can be used to treat opioid overdoses, including heroin, fentanyl and prescription opioids.
  • In March 2024, Perrigo launches the over-the-counter birth control pill Opill, which has been approved by the US Food and Drug Administration. This medication may be purchased without a prescription from in-store and online retailers in the United States.
  • Novartis launched a new program in July 2020 to treat COVID-19 patients in lower-middle-class and low-income nations who are critically ill and do not yet have a vaccination or curative treatment at a reasonable cost.
  • Takeda Pharmaceutical Company Limited stated in March 2021 that it has completed the sale of a portfolio of specific pharmaceuticals to Orifarm Group for a possible US$ 670 million.